Back to results

University of Missouri--Columbia

Evaluation of nanoscale delivery of miR 216 a/b, miR 217, and gemcitabine in pancreatic cancer cell lines

Abstract

dc:description.abstract

Pancreatic cancer is one of the most lethal cancers, and mortality has remained largely unchanged despite advances in cancer diagnostics and therapeutics. MicroRNAs (miRNAs), a class of non-coding RNAs that regulate gene expression, have emerged as potential tools for early detection, prognosis, and therapeutic intervention in PDAC. Tumor-suppressive miRNAs such as miR-216a and miR-217 are typically downregulated in PDAC, and their restoration has been shown to inhibit tumor cell proliferation and promote apoptosis. A pentablock copolymer-based dual delivery nanoscale device (DDND) was developed co-delivers miRNA-216a/b, miRNA-/217 and gemcitabine. In vitro studies on human (Capan-1, MIAPaCa) and murine (KCT-3248) pancreatic cancer cell lines revealed that DDND treatment significantly reduced cell viability, increased apoptosis, and impaired cell migration and colony formation, compared to single-agent or polymer-alone treatments. To determine the underlying molecular mechanisms, Western blot analysis was conducted on lysates and supernatants from treated cells. Target proteins related to apoptosis, epithelial-to-mesenchymal transition, and oncogenic signaling pathways were evaluated. While some expected trends were observed, such as increased BAX expression in apoptotic cell supernatants and elevated E-cadherin in treated cells, many protein expression changes did not align with the hypothesized anti-tumor effects. Further refinement of western blot technique and the evaluation of additional target proteins is required to understand the mechanism through which the DDND treatment works.

Degree

thesis:*
Name thesis:degree_name
M.S.
Level thesis:degree_level
Masters
Discipline thesis:degree_discipline
Biomedical Sciences
Grantor dc:publisher
University of Missouri--Columbia
Year dc:date.issued
2025

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Tran Hoang, Christine
Advisor dc:contributor.advisor
  • Bryan, Jeffrey

Rights

Language dc:language.iso
eng, English

Identifiers

dc:identifier.*
OAI identifier oai:identifier
oai:mospace.umsystem.edu:10355/110319

Chain of custody

source
Harvested from
University of Missouri
Base URL
mospace.umsystem.edu/oai/request
Last updated
2026-07-24
Source record
OAI-PMH GetRecord
related terms
citation

Tran Hoang, Christine. Evaluation of nanoscale delivery of miR 216 a/b, miR 217, and gemcitabine in pancreatic cancer cell lines. Masters thesis, University of Missouri--Columbia, 2025. https://hdl.handle.net/10355/110319